call us : 
send a message : 
Name: paracetamol CAS No.: 103-90-2 Appearance: Colorless crystalline powder Molecular formula: C8H9NO2 Molecular Weight: 151.163 Melting point:168°C-172℃ PACKAGE:25KGS/BAG
Name:Vitamin B1, Thiamine hydrochloride, Vitamin HCL Appearance: white or faintly yellow, crystalline powder CAS No.:50-81-7 Standard:BP2018/EP9.2 Molecular formula: C12H17ClN4OS·HCl
Name: Paracetamol CAS No.: 103-90-2 Appearance: White crystal powder Molecular formula: C8H9NO2 Molecular Weight: 151.1649 Density: 1.293 g/cm3 Melting point: 168-172℃ Water solubility: 14 g/L (20℃) Water solubility: 14 g/L (20 ºC)
Name: Vitamin C, L-Ascorbic acid Specfication: 35% feed grade CAS No.: 50-81-7 Molecular formula: C6H8O6 Appearance: A almost white or light yellow powder Usage: Animal Feed Additive
Name: Sodium Benzoate CAS No.: 532-32-1 EINECS No：208-534-8 Appearance：White granules or crystalline powder Molecular formula: C7H5NaO2 Molecular Weight: 144.1032 Density: 1.44 g/cm³ Melting point: 300℃ Boiling point: 249.3°C at 760 mmHg Flash point: 111.4°C Water solubility: soluble Vapor Pressure: 0.0122mmHg at 25°C
Anhui Sinotech company strictly select GMP products, support customer registration , and provide professional services to chemical customers in the global market.Purchase Sodium Benzoate Ball/Granular CAS NO.:532-32-1,inquiry Anhui Sinotech . Name: Sodium Benzoate Ball/Granular CAS No.: 532-32-1 Molecular formula: C7H5NaO2 Molecular Weight: 144.1032 Melting point: >300°C Boiling point: 249.3°C at 760 mmHg Density：1,44 g/cm3 Molecular structure: Description: Sodium benzoate balls/granules CAS NO.: 532-32-1, is an organic substance. It is white particles. Odorless or slightly benzoin smell. It has a slightly sweet and astringent taste. It is stable in the air, easily soluble in water, and soluble in ethanol, glycerol and methanol. After entering the body, sodium benzoate undergoes a biotransformation process and is excreted with urine without accumulating in the body. As long as it is within the normal dosage range, it is harmless to t...
Welcome to 135th China Import and Export Fair Dear Sir or Madam, The 135th Canton Fair is scheduled to open on April 15, featuring continuous optimization of exhibition structure, various premi...
meloxicam Anhui sinotech industrial co,.ltd
Indroduce
It is suitable for symptomatic treatment of pain, swelling, soft tissue inflammation, traumatic pain and post-operative pain in rheumatoid arthritis and osteoarthritis.
Clinical application
1. oral administration
(1) Osteoarthritis 7.5 mg a day, one-time use, the maximum dose of 15 mg a day;
(2) Ankylosing spondylitis and rheumatoid arthritis 15 mg a day, twice a day, can also be reduced to 7.5 mg a day. The maximum daily dose for adults was 15 mg and that for the elderly was 7.5 mg.
2. Rectal administration
(1) Osteoarthritis, 7.5-15 mg, was inserted into the anus before bedtime;
(2) Ankylosing spondylitis and rheumatoid arthritis, 15 mg or 7.5 mg, were inserted into the anus before bedtime. The elderly 7.5 mg, before going to bed into the anus.
3. Other
Children under the age of 15 are not recommended.
Adverse reactions
Including gastrointestinal reactions (common dyspepsia, nausea, abdominal pain or diarrhea; rare ulcers, bleeding or perforation); anemia, leukopenia or thrombocytopenia, itching, rash; stomatitis; mild dizziness, headache; edema, elevated blood pressure, etc. Common elevated liver enzymes (10%) and occasional renal damage (0.4%). Most disappear after stopping the drug.
Medication contraindication
The following conditions are forbidden: patients with asthma, nasal polyps, angioneurotic edema or urticaria after the use of aspirin or other non-steroidal anti-inflammatory drugs; patients with active peptic ulcer, severe hepatic insufficiency, severe renal insufficiency in non-dialysis patients; patients with gastrointestinal hemorrhage, cerebral hemorrhage or other hemorrhage; patients with severe uncontrolled heart failure; children and years Teenagers under 15 years of age, pregnant women or breastfeeders.
Drug Interaction
1. Combination with methotrexate can increase the blood toxicity of methotrexate.
2. Combination of oral anticoagulant and thrombolytic agents may increase bleeding.
3. It can reduce the antihypertensive and diuretic effects of beta-adrenergic receptor blockers, angiotensin-converting enzyme inhibitors, loop diuretics (except furosemide), thiazide drugs.
4. Combined with potassium-preserving diuretics to reduce diuresis may lead to hyperkalemia or toxic kidney damage.
5. When combined with cyclosporine, the risk of cyclosporine poisoning increased.
6. When combined with levofloxacin and ofloxacin, the risk of seizures increased.
Note: The above contents are only for introduction. Drug use must be carried out under the guidance of doctors in regular hospitals.
安徽施泰化工有限公司
online service
+8613866722531
pweiping@techemi.com
pweiping
+8613866722531